- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05145088
Association Analysis of Aerobic Capacity and Expiratory Forced Vital Capacity in Overweight and Obese Adults After Submaximal Exercise Training of Three Weeks
Association Analysis of Aerobic Capacity and Expiratory Forced Vital Capacity in Overweight and Obese Adults After Submaximal Exercise Training of Three Weeks (a Randomized Controlled Trial Study)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objectives of study:
- To find out association between aerobic capacity and expiratory forced vital capacity in overweight obese adults after submaximal exercise training of 03 weeks.
- To find out effectiveness of submaximal exercise training of 03 weeks on aerobic capacity and expiratory forced vital capacity in overweight obese adults.
STUDY HYPOTHESIS
Alternate hypothesis: There is a significant association between aerobic capacity and expiratory forced vital capacity in overweight obese adults Null hypothesis: There is no significant association between aerobic capacity and expiratory forced vital capacity in overweight obese adults MATERIAL & METHODS
STUDY DESIGN: Randomized control trial SETTING: FUIRS clinical lab DURATION OF STUDY: 1.5 years SAMPLE SIZE: N=30 (sample size validated through tool)
SAMPLING TECHNIQUE: Non probability convenient sampling
Outcome Measures:
Data will be collected on Demographics and general information. VO2 max is being assessed with the help of McArdle Katch test. FVC is being assesed with the help of hand held spirometer device.
Experimental Group (A) = 03 weeks of submaximal exercise according to ACSM guidelines.
Control group (B) =this group is under control with no exercise training.
Data analysis techniques:
The data will be analyzed through SPSS 21 and Data would be analyzed based on the study design chosen that is random control experimental study within the community.
An informed consent is being taken from study participants prior to recruiting in study. After random allocation the participants are being given self-administered PAR-Q followed by pre exercise Expiratory forced vital capacity and VO2 max measurement by the PI.
Significance of study:
This study will make people become aware of their current physical fitness level, so the lifestyle behaviors can be modified if needed, in order to improve their quality of life This study will open new doors for researchers to do long term studies by using different parametes of lungs function test available in hand held spirometer.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dr Summyia Siddique Malik, MSPT
- Phone Number: +923208550611
- Email: summyia.siddique@fui.edu.pk
Study Locations
-
-
Federal
-
Islamabad, Federal, Pakistan, 46000
- Recruiting
- Foundation University Islamabad
-
Contact:
- Dr Summyia
- Email: summyia.siddique@fui.edu.pk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Young adults between age 18 to 35 years
- Classified Overweight and obese adults according to their BMI
Exclusion criteria:
- Any prior history of chronic respiratory illness and chronic cardiac disease.
- Individuals belonging to certain occupations like coal miners, hard rock miners, tunnel workers, concrete manufacturing workers and non-mining industrial workers.
- Individuals with any diagnosed musculoskeletal disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
The participants in this group are under control and not perfoming any exercise, and their life style is NOT consistent with any kind of submaximal exercise training designed as per protocol.
|
|
|
Experimental: Experimental group
the particpants are made to perform submaximal exercise testing according to ACSM guidelines for 03 weeks. For Moderate-intensity exercises includes either 30 min a day for five days a week or a total of two hours and 30 min per week using 50% to 70% of maximum heart rate. The data will be calculated at two times in the form of pre and post testing. |
For Moderate-intensity exercises includes either 30 min a day for five days a week or a total of two hours and 30 min per week using 50% to 70% of maximum heart rate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VO2 max
Time Frame: Day 1
|
It is going to measure the aerobic capacity of the individuals.
|
Day 1
|
|
VO2 max
Time Frame: 3rd week
|
It is going to measure the aerobic capacity of the individuals.
|
3rd week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI
Time Frame: Day 1
|
Change in BMI after submaximal exercise training
|
Day 1
|
|
BMI
Time Frame: 3rd week
|
Change in BMI after submaximal exercise training of 3 weeks.
|
3rd week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dr Summyia Siddique Malik, MSPT, Foundation University Islamabad
- Principal Investigator: Dr Sanna Pervaiz, MSPT, Foundation University Islamabad
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUI/CTR/2021/3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.